NCT00707551View on ClinicalTrials.gov

An Interaction Study of Ketoconazole/Verapamil Versus AZD1305

PHASE1CompletedINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

Healthy

Interventions

DRUG

Ketoconazole

Tablet, administered as repeated doses.

DRUG

Verapamil

Extended Release tablet, administered as repeated doses.

DRUG

AZD1305

Extended Release tablet, administered as a single dose.

Trial Locations (1)

Unknown

Research Site, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY